Press release
Geographic Atrophy Market Anticipated Growth by 2032, as Predicted by DelveInsight | Apellis Pharmaceuticals, Iveric Bio (formerly Ophthotech Corporation), Alkeus Pharmaceuticals, Hemera Biosciences
Geographic Atrophy Market
(Albany, USA) DelveInsight's "Geographic Atrophy Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Geographic Atrophy, historical and forecasted epidemiology as well as the Geographic Atrophy market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.
The Geographic Atrophy market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and the current and forecasted Geographic Atrophy market size from 2019 to 2032, segmented by seven major markets. The Report also covers current Geographic Atrophy treatment practice/algorithm, market drivers, market barriers, and unmet medical needs to curate the best opportunities and assesses the underlying potential of the Geographic Atrophy market.
Request for a Free Sample Report @ Geographic Atrophy Market Forecast [https://www.delveinsight.com/report-store/geographic-atrophy-ga-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=apr]
Some facts of the Geographic Atrophy Market Report are:
* According to DelveInsight, Geographic Atrophy market size is expected to grow at a decent CAGR by 2032.
* Leading Geographic Atrophy companies working in the market are Apellis Pharmaceuticals, Iveric Bio (formerly Ophthotech Corporation), Alkeus Pharmaceuticals, Hemera Biosciences, Allegro Ophthalmics, Stealth BioTherapeutics, Regenerative Patch Technologies, Novartis, Roche, Ionis Pharmaceuticals, CellCure Neurosciences (a subsidiary of Lineage Cell Therapeutics), and others.
* Key Geographic Atrophy Therapies expected to launch in the market are Apellis Pharmaceuticals (Pegcetacoplan), Iveric bio (Zimura), Genentech/ Roche (RO7171009; RG6147), Ionis Pharmaceuticals/ Roche (IONIS-FB-LRx), NGMBiopharmaceuticals (NGM621), Stealth BioTherapeutics (Elamipretide), Regenerative Patch Technologies (CPCB-RPE1), CellCure Neurosciences/ Lineage Cell Therapeutics/ Roche (OpRegen), Novartis (PPY988/GT005), Regenerative Patch Technologies (CPCB-RPE1), Luxa Biotechnology (RPESC-RPE-4W) and others.
* On March 2024, Alexion Pharmaceuticals announced results of a Phase 2, Double-Masked, Placebo-Controlled, Dose Range Finding Study of Danicopan (ALXN2040) in Patients with Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD).
* On March 2024, Genentech announced results of A Phase IIa, Multicenter, Open-Label, Single-Arm Study to Optimize Subretinal Surgical Delivery and to Evaluate Safety and Activity of Opregen in Patients with Geographic Atrophy Secondary to Age-Related Macular Degeneration.
* On April 2024, Boehringer Ingelheim announced results of a study about the Safety, Tolerability, and Pharmacokinetics of Intravitreal Single Rising Doses and Multiple Doses of BI 771716 in Patients With Geographic Atrophy Secondary to Age-related Macular Degeneration (Open Label, Non-randomized).
* On February 2024, Apellis Pharmaceuticals announced results of a Prospective, Multicenter, Open-Label, Observational Phase 4 Study to Evaluate Real-World Safety, Tolerability, and Treatment Patterns of Pegcetacoplan (Syfovre) in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration.
* On March 2024, Janssen Research & Development announced results of a Phase 2b, Randomized, Double-masked, Multicenter, Dose-ranging, Sham-controlled Clinical Trial to Evaluate Intravitreal JNJ-81201887 (AAVCAGsCD59) Compared to Sham Procedure for the Treatment of Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
Geographic Atrophy Overview
Geographic Atrophy, a progressive and irreversible form of age-related macular degeneration (AMD), poses a significant public health concern due to its impact on vision loss among the elderly. Characterized by the degeneration of retinal pigment epithelial cells, Geographic Atrophy leads to central vision impairment and blindness. The condition typically manifests with distinct patches of atrophy in the macula, the central part of the retina responsible for sharp, detailed vision. Currently, there are limited treatment options available, focusing primarily on symptom management and slowing disease progression. Research efforts are underway to develop innovative therapies targeting the underlying mechanisms of Geographic Atrophy. As the global population ages, the prevalence of Geographic Atrophy is expected to rise, highlighting the urgent need for effective interventions to address this sight-threatening condition.
Learn more about Geographic Atrophy treatment algorithms in different geographies, and patient journeys. Contact to receive a sample @ https://www.delveinsight.com/sample-request/geographic-atrophy-ga-market [https://www.delveinsight.com/sample-request/geographic-atrophy-ga-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=apr]
Geographic Atrophy Market
The Geographic Atrophy market outlook of the report helps to build a detailed comprehension of the historical, current, and forecasted Geographic Atrophy market trends by analyzing the impact of current Geographic Atrophy therapies on the market and unmet needs, and drivers, barriers, and demand for better technology.
This segment gives a thorough detail of the Geographic Atrophy market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated Geographic Atrophy market data are presented with relevant tables and graphs to give a clear view of the market at first sight.
According to DelveInsight, the Geographic Atrophy market in 7MM is expected to witness a major change in the study period 2019-2032.
Geographic Atrophy Epidemiology
The Geographic Atrophy epidemiology section provides insights into the historical and current Geographic Atrophy patient pool and forecasted trends for seven individual major countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the Geographic Atrophy market report also provides the diagnosed patient pool, trends, and assumptions.
Explore more about Geographic Atrophy Epidemiology @ Geographic Atrophy Market Dynamics [https://www.delveinsight.com/report-store/geographic-atrophy-ga-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=apr]
Geographic Atrophy Drugs Uptake
This section focuses on the uptake rate of the potential Geographic Atrophy drugs recently launched in the Geographic Atrophy market or expected to be launched in 2019-2032. The analysis covers the Geographic Atrophy market uptake by drugs, patient uptake by therapies, and sales of each drug.
Geographic Atrophy Drugs Uptake helps in understanding the drugs with the most rapid uptake and the reasons behind the maximal use of new drugs and allows the comparison of the drugs based on Geographic Atrophy market share and size, which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.
Geographic Atrophy Pipeline Development Activities
The Geographic Atrophy report provides insights into different therapeutic candidates in Phase II, and Phase III stages. It also analyses Geographic Atrophy key players involved in developing targeted therapeutics.
Request for a sample report to understand more about the Geographic Atrophy pipeline development activities @ https://www.delveinsight.com/sample-request/geographic-atrophy-ga-market [https://www.delveinsight.com/sample-request/geographic-atrophy-ga-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=apr]
Geographic Atrophy Therapeutics Assessment
Major key companies are working proactively in the Geographic Atrophy Therapeutics market to develop novel therapies which will drive the Geographic Atrophy treatment markets in the upcoming years are Apellis Pharmaceuticals, Iveric Bio (formerly Ophthotech Corporation), Alkeus Pharmaceuticals, Hemera Biosciences, Allegro Ophthalmics, Stealth BioTherapeutics, Regenerative Patch Technologies, Novartis, Roche, Ionis Pharmaceuticals, CellCure Neurosciences (a subsidiary of Lineage Cell Therapeutics), and others.
Learn more about the emerging Geographic Atrophy therapies & key companies @ https://www.delveinsight.com/sample-request/geographic-atrophy-ga-market [https://www.delveinsight.com/sample-request/geographic-atrophy-ga-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=apr]
Geographic Atrophy Report Key Insights
1. Geographic Atrophy Patient Population
2. Geographic Atrophy Market Size and Trends
3. Key Cross Competition in the Geographic Atrophy Market
4. Geographic Atrophy Market Dynamics (Key Drivers and Barriers)
5. Geographic Atrophy Market Opportunities
6. Geographic Atrophy Therapeutic Approaches
7. Geographic Atrophy Pipeline Analysis
8. Geographic Atrophy Current Treatment Practices/Algorithm
9. Impact of Emerging Therapies on the Geographic Atrophy Market
Table of Contents
1. Key Insights
2. Executive Summary
3. Geographic Atrophy Competitive Intelligence Analysis
4. Geographic Atrophy Market Overview at a Glance
5. Geographic Atrophy Disease Background and Overview
6. Geographic Atrophy Patient Journey
7. Geographic Atrophy Epidemiology and Patient Population
8. Geographic Atrophy Treatment Algorithm, Current Treatment, and Medical Practices
9. Geographic Atrophy Unmet Needs
10. Key Endpoints of Geographic Atrophy Treatment
11. Geographic Atrophy Marketed Products
12. Geographic Atrophy Emerging Therapies
13. Geographic Atrophy Seven Major Market Analysis
14. Attribute Analysis
15. Geographic Atrophy Market Outlook (7 major markets)
16. Geographic Atrophy Access and Reimbursement Overview
17. KOL Views on the Geographic Atrophy Market
18. Geographic Atrophy Market Drivers
19. Geographic Atrophy Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
About DelveInsight
DelveInsight is a leading Life Science market research and business consulting company recognized for its off-the-shelf syndicated market research reports and customized solutions to firms in the healthcare sector.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=geographic-atrophy-market-anticipated-growth-by-2032-as-predicted-by-delveinsight-apellis-pharmaceuticals-iveric-bio-formerly-ophthotech-corporation-alkeus-pharmaceuticals-hemera-biosciences]
Phone: +91-9650213330
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/consulting
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Geographic Atrophy Market Anticipated Growth by 2032, as Predicted by DelveInsight | Apellis Pharmaceuticals, Iveric Bio (formerly Ophthotech Corporation), Alkeus Pharmaceuticals, Hemera Biosciences here
News-ID: 3465729 • Views: …
More Releases from ABNewswire
Central Florida Notary Express, LLC Expands 24/7 Notary and Mobile Notary Servic …
Winter Park, FL - Central Florida Notary Express, LLC, a 24/7 provider of notary and mobile notary services and certified loan signings, announced expanded same-day coverage across the Greater Orlando area, including Orlando, Winter Park, Maitland, Casselberry, Winter Springs, DeLand, DeBary, Deltona, Sanford, and Lake Mary. The company offers on-site and curbside notarization for jurats, acknowledgments, power of attorney (POA), wills, health care surrogate forms, copy certifications, and real-estate loan…
Stafili Wine Cafe Brings the Heart of Greece to New York City - A Sophisticated …
Nestled in the vibrant neighborhoods of West Village and Tribeca, Stafili Wine Cafe is redefining New York's dining scene with an unforgettable Greek-inspired experience that blends exceptional wines, authentic Mediterranean cuisine, and an inviting, intimate atmosphere. Whether you're seeking a cozy date night, an after-work escape, or a refined venue for social gatherings, Stafili promises an indulgent journey through the flavors, aromas, and spirit of Greece - without ever leaving…
Solar Heroes Launches Premium Solar Control Window Film Solutions in Singapore, …
As Singapore continues to face soaring temperatures and rising energy costs, Solar Heroes, a premium solar control window film supplier and installer, is stepping up to deliver an innovative solution for homes, offices, and commercial spaces. With a commitment to sustainability, comfort, and performance, Solar Heroes is revolutionizing how Singaporeans experience indoor living through advanced solar control window film technology. More information can be found at https://solarheroes.sg.
Singapore - As Singapore…
Dlinxoutreach Unlocks the Power of AI Ecosystems for Companies Seeking Higher RO …
In today's fintech-driven digital economy, artificial intelligence is no longer a speculative technology; it is a monetizable growth driver. Global private investment in AI reached $252 billion in 2024, a 44.5% year-over-year increase according to Stanford's AI Index. In financial services, 77% of executives report achieving positive ROI within the first year of AI deployment, according to Bank Automation News. A Boston Consulting Group study further shows that one in…
More Releases for Geographic
Geographic Information System (GIS) Software Global Market Report 2024 - Geograp …
"The Business Research Company recently released a comprehensive report on the Global Geographic Information System (GIS) Software Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
According to The Business Research Company's, The…
Cybersecurity Market Regional Analysis | Evaluating Geographic Trends
Cybersecurity Market Scope and Overview
In the digital era, where information is the new currency, cybersecurity emerges as a paramount concern for individuals, businesses, and governments alike. With the exponential growth of cyber threats, the global Cybersecurity Market has witnessed a surge in demand for innovative solutions and services to safeguard sensitive data and critical infrastructure. This report delves into a comprehensive analysis of the cybersecurity market, covering key players, market…
Geographic Information System - Comprehensive Analysis
GIS is used to power millions of decisions every day all over the world, such as examining crime patterns, pinpointing novel store locations, directing in-car navigation, and predicting and forecasting the weather, among others. The growing demand for location-based analytics among businesses to enhance operational efficiency and improve decision-making is driving the market growth. Similarly, the necessity to combine traditional data with three-dimensional data to get valuable insights from location-based…
Automobile Accessories Market: Charting New Geographic Territory
An extensive analysis of the Automobile Accessories market strategy of the leading companies in the precision of import/export consumption, supply and demand figures, cost, price, revenue and gross margins. The report starts by an introduction about the company profiling and a comprehensive review about the strategy concept and the tools that can be used to assess and analyze strategy. It also analyzes the company’s strategy in the light of Porter’s…
Geographic Atrophy - Pipeline Review, H2 2018 - ResearchByMarkets.com
"Geographic Atrophy - Pipeline Review, H2 2018", provides an overview of the Geographic Atrophy (Ophthalmology) pipeline landscape.
Geographic atrophy is an advanced form of age-related macular degeneration that can result in the progressive and irreversible loss of retina which can lead to a loss of visual function over time. Symptoms include difficulty during reading. Risk factors include smoking, thyroid hormones or antacids and in patients with coronary heart diseases and cataract…
MapsOfWorld.com partners with National Geographic Maps
MapsOfWorld.com has proudly partnered with National Geographic Maps to sell National Geographic maps and atlases in the United States. All wall maps are available at an initial discount of 15%, along with additional discounts on bulk items ordered by corporations and schools. Range of products available for sale include: paper and laminated wall maps, mural (wall paper) maps, travel maps and atlases. Wall maps are available in National Geographic’s three…
